Not a good buy right now for an impatient trader: the trend is still bearish (SMA_200 > SMA_20 > SMA_5) and price is below the pivot (14.921), so odds favor continued chop/down before any durable reversal.
Options flow is bullish (calls dominate heavily), which supports a possible short-term bounce, but it’s not enough to override the weak technical structure without a confirmed trend turn.
With no proprietary buy signals today and soft/declining operating trends in the latest quarter, the best stance is HOLD / avoid new buys at 14.51 unless you’re explicitly trading an oversold bounce.
Activity: Today’s options volume (246) is ~946% of the 30-day average, indicating unusual attention/speculation.
Open interest: Calls OI 4,474 vs puts OI 76 reinforces a one-sided bullish positioning.
Volatility: HV ~39.1 and IV percentile ~23.6 suggests volatility is not priced at extremes; the bullish tilt is more about directional appetite than panic hedging.
Technical Summary
Sell
9
Buy
1
Positive Catalysts
on 2026-02-23 after hours can serve as a catalyst window.
Neutral/Negative Catalysts
Technical structure remains bearish (below pivot; bearish moving average stack), increasing risk that any bounce fades.
Latest quarter shows weakening top line and margins (revenue down YoY; gross margin down YoY).
No supportive “smart money” trend signals: hedge funds neutral, insiders neutral; no congress trading data to suggest influential accumulation.
Analyst price target was cut (even though rating remained positive), highlighting tempered expectations.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 106.9M, down ~6.15% YoY (negative growth trend).
Profitability: Net income -68.4M and EPS -1.25 (still loss-making; headline YoY “increase” is not quality-positive given the negative level).
Margins: Gross margin 14.41%, down ~6.73% YoY, indicating pressure on operating quality.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
RBC Capital (2025-11-12): Outperform maintained, but price target cut to $19 from $22 after Q3.
Stated focus/catalyst at the time: shareholder meeting (director votes) and portfolio valuation sensitivity (AI/software concerns cited as a near-term drag).
Wall Street pro view (pros): still sees upside to fair value (PT well above 14.51) and potential catalyst-driven re-rating.
Wall Street con view (cons): target cut signals reduced conviction/more conservative outlook; portfolio-valuation and sector sentiment can weigh on near-term performance.
Wall Street analysts forecast CNNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNNE is 19 USD with a low forecast of 19 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CNNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNNE is 19 USD with a low forecast of 19 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.180
Low
19
Averages
19
High
19
Current: 14.180
Low
19
Averages
19
High
19
RBC Capital
Kenneth Lee
Outperform
downgrade
$22 -> $19
AI Analysis
2025-11-12
Reason
RBC Capital
Kenneth Lee
Price Target
$22 -> $19
AI Analysis
2025-11-12
downgrade
Outperform
Reason
RBC Capital analyst Kenneth Lee lowered the firm's price target on Cannae Holdings to $19 from $22 and keeps an Outperform rating on the shares after its Q3 results. The key catalyst remains upcoming December 12 shareholder meeting, with 4 directors up for vote, the analyst tells investors in a research note. RBC adds that broad AI/software concerns may be a drag on some of Cannae's portfolio investment valuations in the near term.
RBC Capital
Kenneth Lee
Outperform
maintain
$22 -> $26
2025-07-10
Reason
RBC Capital
Kenneth Lee
Price Target
$22 -> $26
2025-07-10
maintain
Outperform
Reason
RBC Capital analyst Kenneth Lee raised the firm's price target on Cannae Holdings to $26 from $22 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 results for the U.S. Asset Management industry. The firm cites compounding of AUM from strong market returns seen in Q2 but adding that it would lean towards names with non-US/global AUM exposure, given market returns and the potential for broadening of net flows longer term, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CNNE
